Voya Investment Management LLC Buys 49,884 Shares of Sabra Healthcare REIT, Inc. $SBRA

Voya Investment Management LLC boosted its position in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 13.4% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 422,477 shares of the real estate investment trust’s stock after buying an additional 49,884 shares during the quarter. Voya Investment Management LLC owned 0.18% of Sabra Healthcare REIT worth $7,381,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in SBRA. Strs Ohio purchased a new stake in shares of Sabra Healthcare REIT in the first quarter worth approximately $777,000. Advisors Capital Management LLC increased its stake in Sabra Healthcare REIT by 20.5% in the first quarter. Advisors Capital Management LLC now owns 2,232,609 shares of the real estate investment trust’s stock worth $39,004,000 after purchasing an additional 380,505 shares during the period. Intech Investment Management LLC increased its stake in Sabra Healthcare REIT by 8.4% in the first quarter. Intech Investment Management LLC now owns 245,415 shares of the real estate investment trust’s stock worth $4,287,000 after purchasing an additional 18,915 shares during the period. Focus Partners Wealth lifted its position in shares of Sabra Healthcare REIT by 11.4% during the first quarter. Focus Partners Wealth now owns 23,146 shares of the real estate investment trust’s stock worth $404,000 after purchasing an additional 2,375 shares during the last quarter. Finally, Anchor Investment Management LLC purchased a new stake in shares of Sabra Healthcare REIT during the first quarter valued at $58,000. 99.40% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

SBRA has been the topic of a number of research analyst reports. JMP Securities upped their target price on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a “market outperform” rating in a research note on Wednesday, August 6th. Wells Fargo & Company boosted their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an “overweight” rating in a report on Wednesday, August 27th. Truist Financial raised their price objective on Sabra Healthcare REIT from $18.00 to $20.00 and gave the stock a “hold” rating in a report on Tuesday, September 2nd. Scotiabank upped their target price on Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a “sector perform” rating in a report on Monday, June 23rd. Finally, BMO Capital Markets raised their price target on Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a “market perform” rating in a research note on Monday, August 25th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, Sabra Healthcare REIT presently has a consensus rating of “Moderate Buy” and a consensus price target of $20.83.

Sabra Healthcare REIT Stock Down 0.9%

Shares of Sabra Healthcare REIT stock opened at $18.70 on Thursday. Sabra Healthcare REIT, Inc. has a 52-week low of $15.60 and a 52-week high of $20.03. The firm’s 50 day moving average price is $18.71 and its 200-day moving average price is $18.02. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91. The company has a market cap of $4.48 billion, a P/E ratio of 24.61, a PEG ratio of 1.50 and a beta of 0.88.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.02. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The company had revenue of $189.15 million for the quarter, compared to the consensus estimate of $185.64 million. During the same quarter in the previous year, the firm earned $0.36 EPS. Sabra Healthcare REIT’s revenue was up 7.4% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. On average, sell-side analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, August 29th. Shareholders of record on Friday, August 15th were given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 6.4%. The ex-dividend date of this dividend was Friday, August 15th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 157.89%.

Sabra Healthcare REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.